Red Cat’s Variant 7 Goes Full-Rate as Defense Drone Sector Awaits $1.1 Billion Boost

Red Cat subsidiary Blue Ops starts full-rate production of military-grade V7 USV, driving a 32% surge. Analysts target $20-$22 amid defense spending tailwinds and $1.1B program.

Red Cat has crossed a critical threshold that separates promising developer from credible manufacturer. Its maritime subsidiary Blue Ops has begun full-rate production of the Variant 7 unmanned surface vessel — a military-grade drone that will roll off lines in Georgia and Maine. The move shifts the risk narrative from engineering to execution, and the market has taken notice.

Shares surged 32.61% on Thursday before giving back 7.18% on Friday to close at €11.27. Even with the pullback, the stock is up 39.39% over the past seven days. Year-to-date gains stand at 44.09%, while the twelve-month return clocks in at 112.60%. The wild ride is reflected in an annualized volatility of 143% — a number that underscores just how quickly sentiment can shift in this corner of the defense tech space.

Production ramp and technology stack

The V7 is built to US military specifications for reconnaissance, security, and logistics missions. It uses NDAA-compliant components, a modular open system architecture, and a Steyr motor for propulsion. Blue Ops has integrated swarm intelligence capabilities following Red Cat’s acquisition of Apium Swarm Robotics, while satellite communications come from Kymeta. The company says the production ramp will allow it to scale output on a platform designed for allied forces.

Sector tailwinds and government spending

A broader policy shift is adding fuel to the rally. Reports indicate that the US government is exploring direct investments in domestic drone manufacturers, potentially through a $1.1 billion program aimed at expanding defense drone availability by 2027. For Red Cat, which sits squarely at the intersection of autonomy, US manufacturing, and military applications, that represents a significant demand catalyst — although competition from private players and established defense primes remains fierce.

Analyst conviction and financial footing

Analysts have responded with bullish coverage. H.C. Wainwright initiated with a Buy and a price target of $20. Other firms have followed suit, with targets clustering in the $20 to $22 range — implying substantial upside from current levels. The bullish case rests partly on revenue momentum: Red Cat reported $15.47 million in first-quarter fiscal 2026 revenue. Still, the company remains in investment mode. Analysts expect a negative earnings per share in the second quarter as it pours capital into scaling production.

The balance sheet offers some cushion. Red Cat holds over $130 million in cash, which should fund the expansion phase. The challenge now is converting production milestones into profitable operations and, crucially, securing long-term defense contracts. The technical picture suggests the stock is not overheated despite the recent surge. The relative strength index sits at 43.7 — a neutral reading — and the share price trades 20.90% above its 200-day moving average.

Execution discipline on the factory floor and success in Washington’s procurement pipeline will determine whether Red Cat can turn today’s production start into lasting shareholder value. Both are still unproven, but the conditions for a breakout have never been more clearly laid out.